[논문]BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine

Chao, Po-Kuan; Chang, Hsiao-Fu; Chang, Wan-Ting; Yeh, Teng-Kuang; Ou, Li-Chin; Chuang, Jian-Ying; Tsu-An Hsu, John; Tao, Pao-Luh; Loh, Horace H.; Shih, Chuan; Ueng, Shau-Hua; Yeh, Shiu-Hwa

doi:10.1016/j.neuropharm.2019.107678

BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine

Neuropharmacology, v.166, 2020년, pp.107678 -

Chao, Po-Kuan (Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes) , Chang, Hsiao-Fu (Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes) , Chang, Wan-Ting (Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes) , Yeh, Teng-Kuang (Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes) , Ou, Li-Chin (Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes) , Chuang, Jian-Ying (The PhD Program for Neural Regenerative Medicine, Taipei Medical University) , Tsu-An Hsu, John (Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes) , Tao, Pao-Luh (Center for Neuropsychiatric Research, National Heath Research Institutes) , Loh, Horace H. (Department of Pharmacology, University of Minnesota Medical School) , Shih, Chuan , Ueng, Shau-Hua , Yeh, Shiu-Hwa

Abstract ▼ AI-Helper

Abstract There is unmet need to design an analgesic with fewer side effects for severe pain management. Although traditional opioids are the most effective painkillers, they are accompanied by severe adverse responses, such as respiratory depression, constipation symptoms, tolerance, withdrawal, and addiction. We indicated BPR1M97 as a dual mu opioid receptor (MOP)/nociceptin-orphanin FQ peptide (NOP) receptor full agonist and investigated the pharmacology of BPR1M97 in multiple animal models. In vitro studies on BPR1M97 were assessed using cyclic-adenosine monophosphate production, β-arrestin, internalization, and membrane potential assays. In vivo studies were characterized using the tail-flick, tail-clip, lung functional, heart functional, acetone drop, von Frey hair, charcoal meal, glass bead, locomotor activity, conditioned place preference (CPP) and naloxone precipitation tests. BPR1M97 elicited full agonist properties for all cell-based assays tested in MOP-expressing cells. However, it acted as a G protein-biased agonist for NOP. BPR1M97 initiated faster antinociceptive effects at 10 min after subcutaneous injection and elicited better analgesia in cancer-induced pain than morphine. Unlike morphine, BPR1M97 caused less respiratory, cardiovascular, and gastrointestinal dysfunction. In addition, BPR1M97 decreased global activity and induced less withdrawal jumping precipitated by naloxone. Thus, BPR1M97 could serve as a novel small molecule dual receptor agonist for antinociception with fewer side effects than morphine. This article is part of the Special Issue entitled ‘New Vistas in Opioid Pharmacology’. Highlights BPR1M97 is a novel dual-acting mu opioid receptor (MOP) and nociceptin-orphanin FQ peptide (NOP) receptor full agonist. BPR1M97 was shown to be highly potent and efficacious, and have a noticeably fast onset antinociception in nociceptive tests. BPR1M97 caused less respiratory, cardiovascular, and gastrointestinal dysfunction than morphine.

참고문헌 (63)

Anesthesiology Al-Hasani 115 1363 2011 10.1097/ALN.0b013e318238bba6 Molecular mechanisms of opioid receptor-dependent signaling and behavior

상세보기
Science Bohn 286 2495 1999 10.1126/science.286.5449.2495 Enhanced morphine analgesia in mice lacking beta-arrestin 2

상세보기
Br. J. Pharmacol. Calo 129 1261 2000 10.1038/sj.bjp.0703219 Pharmacology of nociceptin and its receptor: a novel therapeutic target

상세보기
Br. J. Anaesth. Calo 121 1105 2018 10.1016/j.bja.2018.06.024 Nociceptin/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic

상세보기
Nature Cao 392 390 1998 10.1038/32897 Primary afferent tachykinins are required to experience moderate to intense pain

상세보기
Anesthesiology: J. Am. Soc. Anesthesiologists Chao 126 952 2017 10.1097/ALN.0000000000001568 1-(2,4-Dibromophenyl)-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one: a novel opioid receptor agonist with less accompanying gastrointestinal dysfunction than morphine

상세보기
J. Neurosci. Methods Chaplan 53 55 1994 10.1016/0165-0270(94)90144-9 Quantitative assessment of tactile allodynia in the rat paw

상세보기
Eur. J. Med. Chem. Chen 126 202 2017 10.1016/j.ejmech.2016.09.003 Discovery, structure-activity relationship studies, and anti-nociceptive effects of N-(1,2,3,4-tetrahydro-1-isoquinolinylmethyl)benzamides as novel opioid receptor agonists

상세보기
J. Pharmacol. Exp. Ther. Cremeans 343 72 2012 10.1124/jpet.112.194308 Roles of μ-opioid receptors and nociceptin/orphanin FQ peptide receptors in buprenorphine-induced physiological responses in primates

상세보기
Cell. Mol. Neurobiol. Curto-Reyes 28 981 2008 10.1007/s10571-008-9272-3 Local loperamide inhibits thermal hyperalgesia but not mechanical allodynia induced by intratibial inoculation of melanoma cells in mice

상세보기
Anesthesiology Dahan 126 697 2017 10.1097/ALN.0000000000001529 Respiratory effects of the nociceptin/orphanin FQ peptide and opioid receptor agonist, cebranopadol, in healthy human volunteers

상세보기
Nat. Commun. Devilliers 4 2013 10.1038/ncomms3941 Activation of TREK-1 by morphine results in analgesia without adverse side effects

상세보기
J. Pharmacol. Exp. Ther. DeWire 344 708 2013 10.1124/jpet.112.201616 A G protein-biased ligand at the μ-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine

상세보기
Proc. Natl. Acad. Sci. U.S.A. Ding 113 E5511 2016 10.1073/pnas.1605295113 A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates

상세보기
Br. J. Pharmacol. Ding 172 3302 2015 10.1111/bph.13124 Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primates

상세보기
Sci. Transl. Med. Ding 10 2018 10.1126/scitranslmed.aar3483 A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates

상세보기
Neurosci. Lett. Ebert 187 165 1995 10.1016/0304-3940(95)11364-3 Ketobemidone, methadone and pethidine are non-competitive N-methyl-d-aspartate (NMDA) antagonists in the rat cortex and spinal cord

상세보기
J. Biol. Chem. El Kouhen 274 9207 1999 10.1074/jbc.274.14.9207 The absence of a direct correlation between the loss of [d-Ala2,MePhe4,Gly5-ol]Enkephalin inhibition of adenylyl cyclase activity and agonist-induced μ-opioid receptor phosphorylation

상세보기
Curr. Drug Targets Feng 13 230 2012 10.2174/138945012799201612 Current research on opioid receptor function

상세보기
Eur. J. Pharmacol. Fischetti 614 50 2009 10.1016/j.ejphar.2009.04.054 Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24

상세보기
J. Pharmacol. Exp. Ther. Fitting 356 96 2016 10.1124/jpet.115.226407 Morphine tolerance and physical dependence are altered in conditional HIV-1 tat transgenic mice
Am. J. Pathol. Goldsmith 179 673 2011 10.1016/j.ajpath.2011.04.032 Mu opioid signaling protects against acute murine intestinal injury in a manner involving Stat3 signaling

상세보기
J. Med. Chem. Goto 49 847 2006 10.1021/jm0509851 Identification of a novel spiropiperidine opioid receptor-like 1 antagonist class by a focused library approach featuring 3D-pharmacophore similarity

상세보기
Nat. Commun. Grundmann 9 2018 10.1038/s41467-017-02661-3 Lack of beta-arrestin signaling in the absence of active G proteins

상세보기
J. Pharmacol. Exp. Ther. Han 348 316 2014 10.1124/jpet.113.209866 Antinociceptive effects of central administration of the endogenous cannabinoid receptor type 1 agonist VDPVNFKLLSH-OH [(m)VD-hemopressin(α)], an N-terminally extended hemopressin peptide

상세보기
J. Pharmacol. Exp. Ther. Khroyan 336 952 2011 10.1124/jpet.110.175620

상세보기
J. Pharmacol. Exp. Ther. Khroyan 331 946 2009 10.1124/jpet.109.156711 Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/μ-Opioid receptor agonists

상세보기
J. Pharmacol. Exp. Ther. Khroyan 320 934 2007 10.1124/jpet.106.111997 SR 16435 [1-(1-(Bicyclo[3.3.1]nonan-9-yl)piperidin-4-yl)indolin-2-one], a novel mixed nociceptin/orphanin FQ/μ-Opioid receptor partial agonist: analgesic and rewarding properties in mice

상세보기
Adv. Pharmacol. Kiguchi 75 217 2016 10.1016/bs.apha.2015.10.001 Central N/OFQ-NOP receptor system in pain modulation
Br. J. Pharmacol. Kilkenny 160 1577 2010 10.1111/j.1476-5381.2010.00872.x Animal research: reporting in vivo experiments: the ARRIVE guidelines

상세보기
Neuropsychopharmacology Ko vol. 34 2088 2009 10.1038/npp.2009.33 Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys

상세보기
Yonsei Med. J. Lee 46 252 2005 10.3349/ymj.2005.46.2.252 Behavioral characteristics of a mouse model of cancer pain

상세보기
Nucleic Acids Res. Lee 42 13012 2014 10.1093/nar/gku1016 Morphine drives internal ribosome entry site-mediated hnRNP K translation in neurons through opioid receptor-dependent signaling

상세보기
Eur. J. Pharmacol. Liao 606 84 2009 10.1016/j.ejphar.2009.01.036 1-Benzyl-N-[3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl]pyrrolidine-2-carboxamide (Compound 24) antagonizes NOP receptor-mediated potassium channel activation in rat periaqueductal gray slices

상세보기
ACS Chem. Neurosci. Lin 4 214 2013 10.1021/cn300124f The therapeutic potential of nociceptin/orphanin FQ receptor agonists as analgesics without abuse liability

상세보기
J. Pharmacol. Exp. Ther. Linz 349 535 2014 10.1124/jpet.114.213694 Cebranopadol: a novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist

상세보기
Anesthesiology Linz 126 708 2017 10.1097/ALN.0000000000001530 Opioid-type respiratory depressant side effects of cebranopadol in rats are limited by its nociceptin/orphanin FQ peptide receptor agonist activity

상세보기
J. Biol. Chem. Macey 281 34515 2006 10.1074/jbc.M604278200 Mu opioid receptor activation of ERK1/2 is GRK3 and arrestin dependent in striatal neurons

상세보기
Biochim. Biophys. Acta Rev. Canc. Mancino 1816 105 2011 10.1016/j.bbcan.2011.04.005 The neuronal influence on tumor progression

상세보기
Nature Manglik 537 185 2016 10.1038/nature19112 Structure-based discovery of opioid analgesics with reduced side effects

상세보기
J. Neurosci. Mathews 28 12183 2008 10.1523/JNEUROSCI.2326-08.2008 A novel Gβγ-subunit inhibitor selectively modulates μ-opioid-dependent antinociception and attenuates acute morphine-induced antinociceptive tolerance and dependence

상세보기
Int. Rev. Neurobiol. Nash 118 105 2014 10.1016/B978-0-12-801284-0.00005-1 Functions of the chemokine receptor CXCR4 in the central nervous system and its regulation by μ-opioid receptors

상세보기
Therapeut. Clin. Risk Manag. Nersesyan 3 381 2007 Current aproach to cancer pain management: availability and implications of different treatment options
J. Cereb. Blood Flow Metab. Pardridge 32 1959 2012 10.1038/jcbfm.2012.126 Drug transport across the blood-brain barrier

상세보기
Acta Anaesthesiol. Taiwanica Pasternak 49 21 2011 10.1016/j.aat.2010.12.008 Mu opioid receptors in pain management

상세보기
Br. J. Pain Pathan 6 11 2012 10.1177/2049463712438493 Basic opioid pharmacology: an update

상세보기
The Lancet Portenoy 353 1695 1999 10.1016/S0140-6736(99)01310-0 Management of cancer pain

상세보기
J. Pharmacol. Exp. Ther. Raehal 314 1195 2005 10.1124/jpet.105.087254 Morphine side effects in beta-arrestin 2 knockout mice

상세보기
Pharmacol. Res. Perspect. Rizzi 4 2016 10.1002/prp2.247 Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist

상세보기
J. Pharmacol. Exp. Ther. Ross 327 561 2008 10.1124/jpet.108.143438 Morphine tolerance in the mouse ileum and colon

상세보기
J. Neurosci. Rusin 17 6565 1997 10.1523/JNEUROSCI.17-17-06565.1997 κ-Opioid receptor activation modulates Ca2+Currents and secretion in isolated neuroendocrine nerve terminals

상세보기
Addict. Sci. Clin. Pract. Savage 4 4 2008 10.1151/ascp08424 Challenges in using opioids to treat pain in persons with substance use disorders

상세보기
Nat. Neurosci. Schuller 2 151 1999 10.1038/5706 Retention of heroin and morphine-6β-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1

상세보기
EMBO J. Schulz 23 3282 2004 10.1038/sj.emboj.7600334 Morphine induces terminal μ-opioid receptor desensitization by sustained phosphorylation of serine-375

상세보기
J. Pharmacol. Exp. Ther. Sobczak 348 401 2014 10.1124/jpet.113.209825 Anti-inflammatory and antinociceptive action of an orally available nociceptin receptor agonist SCH 221510 in a mouse model of inflammatory bowel diseases

상세보기
J. Biol. Chem. Tan 284 6270 2009 10.1074/jbc.M806742200 p38 MAPK and β-arrestin 2 mediate functional interactions between endogenous μ-opioid and α(2A)-adrenergic receptors in neurons

상세보기
J. Pharmacol. Exp. Ther. Toll 331 954 2009 10.1124/jpet.109.157446 Comparison of the antinociceptive and antirewarding profiles of novel bifunctional nociceptin receptor/μ-opioid receptor ligands: implications for therapeutic applications

상세보기
Addict. Biol. Tzschentke 23 1010 2018 10.1111/adb.12550 Limited potential of cebranopadol to produce opioid-type physical dependence in rodents

상세보기
Pain Pract. Tzschentke 17 1032 2017 10.1111/papr.12558 Antihyperalgesic, antiallodynic, and antinociceptive effects of cebranopadol, a novel potent nociceptin/orphanin FQ and opioid receptor agonist, after peripheral and central administration in rodent models of neuropathic pain

상세보기
Neuropsychopharmacology Urs 36 551 2011 10.1038/npp.2010.186 A dopamine D1 receptor-dependent β-arrestin signaling complex potentially regulates morphine-induced psychomotor activation but not reward in mice

상세보기
Proc. Natl. Acad. Sci. U.S.A. Wang 109 6325 2012 10.1073/pnas.1200130109 Morphine activates neuroinflammation in a manner parallel to endotoxin

상세보기
Br. J. Pharmacol. Wang 173 856 2016 10.1111/bph.13394 Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4

상세보기
Pharmacol. Rev. Williams 65 223 2013 10.1124/pr.112.005942 Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance

상세보기

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine

Abstract ▼ AI-Helper

참고문헌 (63)

이 논문을 인용한 문헌

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트